Prognostic Significance of Creeping Proteinuria in the First Year After Transplantation

被引:6
作者
Calabuig, Asuncion Sancho [1 ]
Martinez, Eva Gavela [1 ]
Berga, Julia Kanter [1 ]
Catalan, Sandra Beltran [1 ]
Bernabeu, Ana Isabel Avila [1 ]
Mateu, Luis Manuel Pallardo [1 ,2 ]
机构
[1] Hosp Univ Dr Peset, Dept Nephrol, Valencia, Spain
[2] Univ Valencia, Dept Med, Valencia, Spain
关键词
CHRONIC KIDNEY-DISEASE; RENAL-DISEASE; PROGRESSION; GRAFT; REDUCTION; DIAGNOSIS; SURVIVAL; CRITERIA; TARGET; RISK;
D O I
10.1097/TP.0000000000000775
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Proteinuria changes have a prognostic significance in proteinuric nephropathies. Proteinuria has been related to kidney transplant outcomes, but there are no information about the impact of increasing proteinuria during the first year on long-term graft and patient survival. Methods. Retrospective cohort study of 591 kidney transplants to analyze the effect on long-term prognosis of: proteinuria at 3 (n = 591) and 12 (n = 583) months (no proteinuria: 150-299 mg/24 hours, 300-999 mg/24 hours, and >= 1 g/24 hours), and changes in proteinuria during the first year in such patients with proteinuria at 3 months (reduction >= 50% of proteinuria from 3 to 12 months, variation <50%, and increase >= 50% or "creeping proteinuria") (n=283). Results. Higher levels of proteinuria, at both 3 and 12 months, were progressively related to lower graft survival (P < 0.0001). Proteinuria at 12 months was related to mortality (P = 0.026). Creeping proteinuria, which was present in 35 patients (12.4%), was related to graft failure (P < 0.0001) and mortality (P = 0.030), even at lower levels of proteinuria at 3 months. De novo HLA antibody development was the only factor related to creeping proteinuria (hazard ratio, 2.946; 95% confidence interval, 1.158-7.491; P = 0.023). Conclusions. Creeping proteinuria during the first year was associated with long-term graft failure and mortality and could be considered as a surrogate of kidney disease progression in the renal transplant population, as it is in proteinuric nephropathies. It could also be viewed as an expression of immunological damage.
引用
收藏
页码:2598 / 2607
页数:10
相关论文
共 38 条
[1]   Proteinuria after kidney transplantation, relationship to allograft histology and survival [J].
Amer, H. ;
Fidler, M. E. ;
Myslak, M. ;
Morales, P. ;
Kremers, W. K. ;
Larson, T. S. ;
Stegall, M. D. ;
Cosio, F. G. .
AMERICAN JOURNAL OF TRANSPLANTATION, 2007, 7 (12) :2748-2756
[2]   Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy [J].
Atkins, RC ;
Briganti, EM ;
Lewis, JB ;
Hunsicker, LG ;
Braden, G ;
de Crespigny, PJC ;
DeFerrari, G ;
Drury, P ;
Locatelli, F ;
Wiegmann, TB ;
Lewis, EJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2005, 45 (02) :281-287
[3]   Screening for proteinuria in US adults - A cost-effectiveness analysis [J].
Boulware, LE ;
Jaar, BG ;
Tarver-Carr, ME ;
Brancati, FL ;
Powe, NR .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (23) :3101-3114
[4]   Predictors of the progression of renal insufficiency in patients with insulin-dependent diabetes and overt diabetic nephropathy [J].
Breyer, JA ;
Bain, RP ;
Evans, JK ;
Nahman, NS ;
Lewis, EJ ;
Cooper, M ;
McGill, J ;
Berl, T ;
Rohde, R ;
Hunsicker, LG ;
Lachin, J ;
Greenhouse, SW ;
Verme, DA ;
Turlington, TR ;
Burrows, PK ;
Wish, J ;
Sheehan, J ;
Pohl, M ;
Berl, T ;
Santiago, G ;
Hunsicker, L ;
Kern, EFO ;
Lemann, J ;
Blementhal, S ;
Bresnahan, BS ;
Hebert, L ;
Goldfarb, S ;
Kobrin, S ;
Rodby, R ;
Levey, A ;
McLaughlin, M ;
Williams, M ;
McGill, J ;
Whittler, F ;
Rutecki, G ;
Cattran, D ;
Lietz, S ;
Valaitis, D ;
Hano, J ;
Maxwell, D ;
Porush, J ;
Spitalewitz, S ;
Shapiro, K ;
Adler, S ;
Tolchin, N ;
Hoy, W ;
Bernstein, R ;
Svetkey, L ;
Sharon, Z ;
Rausenbaum, B .
KIDNEY INTERNATIONAL, 1996, 50 (05) :1651-1658
[5]   The Clinical Significance of Early Proteinuria After Renal Transplantation [J].
Cherukuri, Aravind ;
Welberry-Smith, Matthew P. ;
Tattersall, James E. ;
Ahmad, Niaz ;
Newstead, Chas G. ;
Lewington, Andrew J. P. ;
Baker, Richard J. .
TRANSPLANTATION, 2010, 89 (02) :200-207
[6]   Rapid resolution of proteinuria of native kidney origin following live donor renal transplantation [J].
D'Cunha, PT ;
Parasuraman, R ;
Venkat, KK .
AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (02) :351-355
[7]   Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: Lessons from RENAAL [J].
de Zeeuw, D ;
Remuzzi, G ;
Parving, HH ;
Keane, WF ;
Zhang, ZX ;
Shahinfar, S ;
Snapinn, S ;
Cooper, MF ;
Mitch, WE ;
Brenner, BM .
KIDNEY INTERNATIONAL, 2004, 65 (06) :2309-2320
[8]   Mycophenolate mofetil substitution for cyclosporine A in renal transplant recipients with chronic progressive allograft dysfunction: the "creeping creatinine" study [J].
Dudley, C ;
Pohanka, E ;
Riad, H ;
Dedochova, J ;
Wijngaard, P ;
Sutter, C ;
Silva, HT .
TRANSPLANTATION, 2005, 79 (04) :466-475
[9]   Proteinuria:: a new marker of long-term graft and patient survival in kidney transplantation [J].
Fernández-Fresnedo, G ;
Plaza, JJ ;
Sánchez-Plumed, J ;
Sanz-Guajardo, A ;
Palomar-Fontanet, R ;
Arias, M .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2004, 19 :47-51
[10]   Induction Treatment With Low-Dose Thymoglobulin or Basiliximab in Renal Transplants From Older Donors [J].
Gavela Martinez, E. ;
Sancho Calabuig, A. ;
Escudero Quesada, V. ;
Avila Bernabeu, A. L. ;
Beltran Catalan, S. ;
Morales Garcia, A. L. ;
Crespo Albiach, J. F. ;
Pallardo Mateu, L. M. .
TRANSPLANTATION PROCEEDINGS, 2008, 40 (09) :2900-2902